ModelEdge

Cero Therapeutics Holdings, Inc.
PBAX
Filing Type10-Q
Filing Date11/18/2025
Updated11/19/25, 2:10 PM

Filing

10-Q
Earnings Release

Exhibits

10-QQ3
EX-10.5AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT, BY AND AMONG CERO THERAPEUTICS HOLDINGS, INC. AND THE INVESTORS SIGNATORY THERETO, DATED AS OF OCTOBER 16, 2025
EX-10.6FORM OF AMENDMENT AND LIMITED WAIVER AGREEMENT, BY AND AMONG CERO THERAPEUTICS HOLDINGS, INC. AND THE HOLDERS SIGNATORY THERETO, DATED AS OF AUGUST 13, 2025
EX-31.1CERTIFICATION
EX-31.2CERTIFICATION
EX-32.1CERTIFICATION
EX-32.2CERTIFICATION